Key result
The P-POSSUM scale demonstrated poor performance for predicting 30-day postoperative morbidity in patients undergoing cytoreductive surgery for ovarian cancer (p=0.05949).
Why the study?
Evidence on the performance of the P-POSSUM scale in predicting outcomes after cytoreductive surgery for ovarian cancer is limited.
Does the P-POSSUM scale accurately predict 30-day postoperative morbidity and mortality in patients undergoing cytoreductive surgery for ovarian cancer?
Cohort
Yes
Does the P-POSSUM scale accurately predict 30-day postoperative morbidity and mortality in patients undergoing cytoreductive surgery for ovarian cancer?
p-value: p=0.05949
The P-POSSUM scale is inadequate for predicting surgical morbidity in ovarian cancer cytoreductive surgery, highlighting the need for new, validated predictive models.
P-POSSUM should not guide risk assessment in ovarian cancer cytoreductive surgery; this Level 3 cohort study leaves open validation of improved models.
No takes yet. Share an insight, caveat, or question.
Sideris et al. (2025) conducted a cohort in Ovarian cancer undergoing cytoreductive surgery. P-POSSUM scale vs. Proposed predictive model was evaluated on 30-day postoperative morbidity and mortality classified using the Clavien-Dindo scale (p=0.05949). The P-POSSUM scale demonstrated poor performance for predicting 30-day postoperative morbidity in patients undergoing cytoreductive surgery for ovarian cancer (p=0.05949).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: